Author:
Mangia Alessandra,Piazzolla Valeria
Subject
Gastroenterology,Hepatology
Reference23 articles.
1. FDA approves Sovaldi for chronic hepatitis C. FDA news release US food and Drug administration. 2013-12-06.
2. European Medicines Agency recommends approval of sofosbuvir for the treatment of chronic hepatitis C EMA/717004/2013.
3. Discovery of a β-d-2′-deoxy-2′-α-fluoro-2′-β-C-methyluridine nucleotide prodrug (PSI-7977) for the treatment of hepatitis C virus;Sofia;Journal of Medicinal Chemistry,2010
4. Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus;Lam;Antimicrobial Agents and Chemotherapy,2012
5. Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C;Gane;New England Journal of Medicine,2013
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献